Vivisol Srl

What Vivisol Srl does

Vivisol S.r.l. is an Italian home healthcare provider founded in 1989 in Monza as a wholly-owned subsidiary of SOL S.p.A., a multinational medicinal and industrial gases producer established in 1927. The company operates across approximately 20 countries in Europe, South America, and the Middle East, serving 870,000 patients through a portfolio organized around nine core therapeutic areas: oxygen therapy, ventilatory support, sleep-related respiratory disturbances, aerosol therapy, artificial nutrition, infusion therapy, medical care at home, assistive device management, and telemedicine. Vivisol claims the number-one position in Italy by days of home assistance provided in artificial nutrition.

The technology platform combines proprietary telemedicine and cloud-based compliance monitoring tools (Viviopen and Vivicheck digital systems, introduced at ERS 2022) with assistive-device management software, oxygen delivery hardware (liquid containers, fixed and portable concentrators, compressed tanks), sleep apnea diagnostics (CPAP, AutoCPAP, Bilevel, polysomnography), mechanical ventilation devices, and infusion pumps. An AI cooperation with Almawave, building on the RicovAI-19 COVID-19 pilot, extends capabilities into AI-powered patient compliance monitoring. Recent acquisitions (Aenduo in Italy for telemedicine software, Medair in Romania, Oxigenar/Pulmonair in Brazil, Remeo in the UK) have added capabilities and geographic reach.

Vivisol's business model is dominated by managed-services contracts with national and regional public health systems (Italy's SSN, the UK NHS, and equivalents), with reimbursement governed by essential assistance levels (LEA) and national prosthesis tariff frameworks. B2C operations exist through Vivisol Brasil (home respiratory care) and Vivisol Hellas retail stores, but these are supplementary to the core government-contracted revenue base. Distribution leverages country-specific subsidiary brands (France Oxygene, Infusol, Medseven, Medair, Dolby Healthcare) and participation in major European medical congresses (ERS, ESPEN, EuroPD, World Sleep Congress) to engage healthcare professionals.

Name

Vivisol Srl

Legal name

VIVISOL S.r.l.

Website

https://vivisol.com

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

1,001–5,000 employees

Short description

Vivisol Srl is an Italian home healthcare provider serving 870,000 patients across roughly 20 countries with oxygen therapy, ventilation, artificial nutrition, infusion therapy, and telemedicine services, operating primarily through contracts with national public health systems as a subsidiary of SOL Group.

Ownership category

akta.pro rank

Headquarters

HQ city

Monza

HQ country

Italy

HQ region

Europe

Offices6 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. National Health System Contracts: Vivisol provides home care services commissioned by national and regional healthcare systems (e.g., SSN in Italy, NHS in the UK). Services are delivered through public-private partnerships and regional procurement frameworks, with reimbursement structured around care levels (Levels I, II, III) and national health tariff systems.
2. Home Respiratory Care (B2C): In Brazil, Vivisol Brasil operates a business-to-consumer (B2C) model for home respiratory care, selling directly to patients and families.
3. Artificial Nutrition Services: Turnkey home nutrition services (enteral and parenteral) commissioned by health services, with supply of nutritional formulas and feeding systems. Vivisol claims to be the number one national operator in Italy in terms of days of assistance provided.
4. Assistive Device Management: Management and delivery of therapeutic assistive devices ( prosthetics lists 1, 2, 3 per NTP) for regional health authorities, including sanitisation, maintenance, and inventory management services.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Vivisol Srl delivers home-based medical care services across nine therapeutic areas: oxygen therapy, ventilatory support, sleep-related respiratory disturbances, aerosol therapy, artificial nutrition, infusion therapy, at-home medical care, assistive device management, and telemedicine. The company supplies, installs, maintains and sanitizes therapeutic devices, provides patient and caregiver training, and operates remote monitoring platforms under contracts with national and regional public health systems.

Product overview

Vivisol Srl is one of Europe's largest home care providers, founded in 1989 by SOL Group. The company offers a comprehensive portfolio of home care services organized around nine core therapeutic areas: Oxygen Therapy, Ventilatory Therapy, Sleep-Related Respiratory Disturbances, Aerosol Therapy, Artificial Nutrition, Infusion Therapy, Medical Care at Home, Assistive Device Management, and Telemedicine. Services range from medical equipment provision and therapy administration to remote patient monitoring. The portfolio includes proprietary digital platforms (Viviopen, Vivicheck) for patient management and compliance monitoring. Vivisol operates through a network of subsidiaries across Europe and internationally, including ViviCare, Dolby Healthcare, France Oxygene, and Medair, providing integrated home healthcare solutions to patients, physicians, and national health systems.

Differentiator

Problem solved

Functional benefit

Brands

• Vivivicare: Home care services brand under the Vivisol umbrella
• France Oxygene
• Infusol
• Oxigenar
• Pulmonair
• Remeo

Products and services

• Oxygen Therapy

Quantifiable outcome

• 870,000 patients served globally
• +3 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature7 records

Partnerships

Seven partnerships are on record, tiered core.

• AlmawavecoreTechnology or IntegrationVivisol and Almawave established a new cooperation to apply Artificial Intelligence solutions in home care services, following the successful RicovAI-19 experimentation in the Marche Region to combat COVID-19. The partnership aims to improve patient compliance in home therapies through AI-powered monitoring and follow-up platforms.
• Oxigenar and PulmonaircoreStrategic or Co-development PartnerVivisol Brasil (wholly controlled by SOL S.p.A.) acquired 70% of Oxigenar and Pulmonair, a group based in Rio de Janeiro active in the B2C home respiratory care sector in Brazil. This acquisition strengthens SOL Group's position in South America's home respiratory care market.
• MEDAIR OXIGEN SOLUTION S.R.L. (Medair)coreStrategic or Co-development PartnerAirsol S.r.l. (100% controlled by SOL S.p.A.) acquired 70% of Medair S.r.l., a Bucharest-based company and one of Romania's leading home respiratory care operators, founded in 2016 by Catalin Batrinu. Medair achieved ~€2.4M revenue in 2023 with 36 employees. Post-acquisition, Catalin Batrinu retains 30% and continues as CEO.
• Remeo Healthcare Limited and Remeo Property Limited (Remeo)coreStrategic or Co-development PartnerDolby Healthcare Limited (100% indirect subsidiary of SOL S.p.A.) acquired 100% of Remeo Healthcare Limited and Remeo Property Limited from Active Care Group. Remeo operates the Lane Fox Remeo Respiratory Centre — a 20-bed specialist respiratory care facility in Redhill, Surrey, UK — working in close collaboration with Guy's and St Thomas' NHS Foundation Trust.
• Aenduo s.r.l.coreStrategic or Co-development PartnerAirsol S.r.l. (100% subsidiary of SOL S.p.A.) acquired 80% of Aenduo s.r.l., an Italian software company, with founder Marcello Pediconi retaining 20%. The acquisition strengthens SOL Group's telemedicine solutions through innovative software development.
• Guy's and St Thomas' NHS Foundation TrustcoreStrategic or Co-development PartnerThe Lane Fox Remeo Respiratory Centre (operated by Dolby Healthcare Limited / Vivisol UK) works in close collaboration with Guy's and St Thomas' NHS Foundation Trust, one of the UK's leading NHS foundation trusts, for specialist respiratory care services.
• VIVISOL Subsidiary Brands and CompaniescoreOthersVivisol operates through a network of subsidiary and affiliate brands across multiple countries: ViviCare, Global Care Group (Brazil), France Oxygene, Infusol.fr, SSZ Allershausen, Intensivpflege Kompass, Il Point, iTOP, Mbar, Medtek GmbH, Intensivservice, Medseven (Poland), Medair (Romania), Perspecta, SITEX (Switzerland), Nemo Lab, Pallmed (Poland), and others — covering respiratory care, infusion therapy, home care, assistive devices, and palliative care.

Scale indicators7 records

Recent moves11 records

Expansion highlights6 records

Direct peers

• Apria Healthcare: US-focused home medical equipment and home respiratory care provider (now part of Owens & Minor); directly comparable to Vivisol in home oxygen, ventilation, sleep, and infusion services at multi-state scale.
• Messer Group: Private German industrial and medical gases group operating home respiratory care across Europe; directly comparable to Vivisol on home oxygen and chronic respiratory services, with similar private/family-owned DNA.
• Option Care Health: Largest US independent provider of home and alternate-site infusion services, including clinical nutrition and specialty drug infusion; directly comparable to Vivisol's home infusion therapy and artificial nutrition lines.
• Fisher & Paykel Healthcare: Manufacturer and supplier of respiratory care and home ventilation products, with strong European hospital and home-care distribution; comparable to Vivisol on the device and consumable side of home respiratory care.
• ResMed: Global leader in sleep apnea and respiratory care devices (CPAP, bilevel) plus cloud-based patient compliance platforms; directly comparable to Vivisol's sleep-related respiratory disturbances offering and over-the-air monitoring stack.
• Nestlé Health Science: Global leader in clinical nutrition products and home enteral/parenteral feeding services; directly comparable to Vivisol's artificial nutrition franchise, where Vivisol claims #1 in Italy by days of home assistance.
• Linde Healthcare: Healthcare division of Linde plc, a leading provider of home medical gases, respiratory therapies, and sleep apnea treatment in Europe; competes head-to-head with Vivisol in oxygen, ventilation, and sleep services.
• Amedisys: US home health and hospice provider operating skilled nursing, therapy, and chronic disease management at home; directly comparable to Vivisol on the multi-therapy home health platform model and government-payer contracts.
• B. Braun Avitum / B. Braun HomeCare: German medical device and healthcare services group with home-care divisions covering infusion therapy, clinical nutrition, and home dialysis; comparable to Vivisol in infusion and nutrition service delivery in European markets.
• Air Liquide Healthcare: Healthcare arm of Air Liquide, one of the largest global home respiratory care and home oxygen therapy providers; directly comparable to Vivisol in oxygen therapy, ventilation, and chronic home care services across Europe and Latin America.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/vivisolbrasil

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Subsidiaries15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vivisol Srl